Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.
Buysschaert
Martin
M
Department of Endocrinology and Nutrition, Cliniques Universitaires St Luc, Université Catholique de Louvain, Bruxelles, Belgium.
Cosyns
Jean-Pierre
JP
Barreto
Leonel
L
Jadoul
Michel
M
D000368:Aged; D001707:Biopsy, Needle; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005198:Fanconi Syndrome / Q000150:complications / Q000175:diagnosis*; D005500:Follow-Up Studies; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D007150:Immunohistochemistry; D008297:Male; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology*; D000077268:Pamidronate; D010280:Parathyroid Glands / Q000473:pathology / Q000601:surgery; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler
D004164:Diphosphonates; D000077268:Pamidronate